
Office of Communications
and Public Liaison (OCPL)
Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
Phone: 301-496-1752
nianews3@mail.nih.gov
NIA is the lead Federal agency for supporting and conducting Alzheimer's disease research. For NIA background information on this topic see:
See NIA research news related to Alzheimer's disease below.
Allopregnanolone, a metabolite of the hormone progesterone that is made in the central nervous system, reversed neurological decline and improved performance on memory tests in 3-month-old mice with characteristics of Alzheimer's...
Scientists have discovered that a gene linked to Alzheimer’s disease may play a beneficial role in cell survival by enabling neurons to clear away toxic proteins. A study funded by the National Institute on Aging (NIA), part of the...
American Recovery and Reinvestment Funds are being used to promote the national research efforts to better understand, diagnose and treat Alzheimer’s disease. The National Institute on Aging (NIA), part of the National Institutes of...
In the largest genome-wide association study (GWAS) reported to date involving Alzheimer’s disease, scientists have identified two new possible genetic risk factors for late-onset Alzheimer’s, the most common form of the...
Two recent NIA-funded studies used novel imaging techniques to explore the possible connection between the buildup of beta-amyloid protein deposits in the brains in living people and the risk of developing Alzheimer’s disease (AD)....
A recent article about a population-based study in England reports that exposure to secondhand smoke could increase the odds of older nonsmokers becoming cognitively impaired. In work funded in part by the NIA, researchers measured levels...
The adult children of people diagnosed with inherited Alzheimer's disease are the focus of a new study to better understand the biology of the disease. Researchers are seeking 300 volunteers with a biological parent with a known...
The dietary supplement Ginkgo biloba was found to be ineffective in reducing the development of dementia and Alzheimer's disease in older people, according to a study published in the "Journal of the American Medical Association...
Scientists have long questioned whether the abundant amounts of amyloid plaques found in the brains of patients with Alzheimer’s actually caused the neurological disease or were a by-product of its progress. Now, using new research...
Cognitively normal people with a maternal family history of Alzheimer’s disease (AD) show reductions in their cerebral glucose metabolism in the same brain areas as those seen in people who have been diagnosed with AD, according to...